Get 20% lifetime commission for referring investors to digrin.com
here.
Fulcrum Therapeutics, Inc. ( FULC) - Key Metrics
FULC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.34 | -$0.21 | -$0.21 |
| 2026Q1 | $0 | -$0.25 | -$0.25 | -$0.25 |
| 2025Q4 | $0 | -$0.32 | -$0.27 | -$0.27 |
| 2025Q3 | $0 | -$0.31 | -$0.23 | -$0.23 |
| 2025Q2 | $0 | -$0.28 | -$0.22 | -$0.22 |
FULC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.69 |
| 2026Q1 | 0% | -7.67 |
| 2025Q4 | 0% | -9.12 |
| 2025Q3 | 0% | -7.42 |
| 2025Q2 | 0% | -6.14 |
FULC
Price: $3.80
52 week price:
Earnings Per Share: -1.17 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 493900
Market Capitalization: 286.1 million